1 Study Coverage
    1.1 Non-Invasive Glucose Monitoring Product Introduction
    1.2 Market by Type
        1.2.1 Global Non-Invasive Glucose Monitoring Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Wearable Blood Glucose Monitoring Systems
        1.2.3 Table Top Blood Glucose Monitoring Systems
    1.3 Market by Application
        1.3.1 Global Non-Invasive Glucose Monitoring Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Non-Invasive Glucose Monitoring Sales Estimates and Forecasts 2017-2028
    2.2 Global Non-Invasive Glucose Monitoring Revenue Estimates and Forecasts 2017-2028
    2.3 Global Non-Invasive Glucose Monitoring Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Non-Invasive Glucose Monitoring Sales by Region
        2.4.1 Global Non-Invasive Glucose Monitoring Sales by Region (2017-2022)
        2.4.2 Global Sales Non-Invasive Glucose Monitoring by Region (2023-2028)
    2.5 Global Non-Invasive Glucose Monitoring Revenue by Region
        2.5.1 Global Non-Invasive Glucose Monitoring Revenue by Region (2017-2022)
        2.5.2 Global Non-Invasive Glucose Monitoring Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Non-Invasive Glucose Monitoring Sales by Manufacturers
        3.1.1 Global Top Non-Invasive Glucose Monitoring Manufacturers by Sales (2017-2022)
        3.1.2 Global Non-Invasive Glucose Monitoring Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Non-Invasive Glucose Monitoring in 2021
    3.2 Global Non-Invasive Glucose Monitoring Revenue by Manufacturers
        3.2.1 Global Non-Invasive Glucose Monitoring Revenue by Manufacturers (2017-2022)
        3.2.2 Global Non-Invasive Glucose Monitoring Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Non-Invasive Glucose Monitoring Revenue in 2021
    3.3 Global Non-Invasive Glucose Monitoring Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Non-Invasive Glucose Monitoring Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Non-Invasive Glucose Monitoring Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Non-Invasive Glucose Monitoring Sales by Type
        4.1.1 Global Non-Invasive Glucose Monitoring Historical Sales by Type (2017-2022)
        4.1.2 Global Non-Invasive Glucose Monitoring Forecasted Sales by Type (2023-2028)
        4.1.3 Global Non-Invasive Glucose Monitoring Sales Market Share by Type (2017-2028)
    4.2 Global Non-Invasive Glucose Monitoring Revenue by Type
        4.2.1 Global Non-Invasive Glucose Monitoring Historical Revenue by Type (2017-2022)
        4.2.2 Global Non-Invasive Glucose Monitoring Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Non-Invasive Glucose Monitoring Revenue Market Share by Type (2017-2028)
    4.3 Global Non-Invasive Glucose Monitoring Price by Type
        4.3.1 Global Non-Invasive Glucose Monitoring Price by Type (2017-2022)
        4.3.2 Global Non-Invasive Glucose Monitoring Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Non-Invasive Glucose Monitoring Sales by Application
        5.1.1 Global Non-Invasive Glucose Monitoring Historical Sales by Application (2017-2022)
        5.1.2 Global Non-Invasive Glucose Monitoring Forecasted Sales by Application (2023-2028)
        5.1.3 Global Non-Invasive Glucose Monitoring Sales Market Share by Application (2017-2028)
    5.2 Global Non-Invasive Glucose Monitoring Revenue by Application
        5.2.1 Global Non-Invasive Glucose Monitoring Historical Revenue by Application (2017-2022)
        5.2.2 Global Non-Invasive Glucose Monitoring Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Non-Invasive Glucose Monitoring Revenue Market Share by Application (2017-2028)
    5.3 Global Non-Invasive Glucose Monitoring Price by Application
        5.3.1 Global Non-Invasive Glucose Monitoring Price by Application (2017-2022)
        5.3.2 Global Non-Invasive Glucose Monitoring Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Non-Invasive Glucose Monitoring Market Size by Type
        6.1.1 North America Non-Invasive Glucose Monitoring Sales by Type (2017-2028)
        6.1.2 North America Non-Invasive Glucose Monitoring Revenue by Type (2017-2028)
    6.2 North America Non-Invasive Glucose Monitoring Market Size by Application
        6.2.1 North America Non-Invasive Glucose Monitoring Sales by Application (2017-2028)
        6.2.2 North America Non-Invasive Glucose Monitoring Revenue by Application (2017-2028)
    6.3 North America Non-Invasive Glucose Monitoring Market Size by Country
        6.3.1 North America Non-Invasive Glucose Monitoring Sales by Country (2017-2028)
        6.3.2 North America Non-Invasive Glucose Monitoring Revenue by Country (2017-2028)
        6.3.3 United States
        6.3.4 Canada
7 Europe
    7.1 Europe Non-Invasive Glucose Monitoring Market Size by Type
        7.1.1 Europe Non-Invasive Glucose Monitoring Sales by Type (2017-2028)
        7.1.2 Europe Non-Invasive Glucose Monitoring Revenue by Type (2017-2028)
    7.2 Europe Non-Invasive Glucose Monitoring Market Size by Application
        7.2.1 Europe Non-Invasive Glucose Monitoring Sales by Application (2017-2028)
        7.2.2 Europe Non-Invasive Glucose Monitoring Revenue by Application (2017-2028)
    7.3 Europe Non-Invasive Glucose Monitoring Market Size by Country
        7.3.1 Europe Non-Invasive Glucose Monitoring Sales by Country (2017-2028)
        7.3.2 Europe Non-Invasive Glucose Monitoring Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Non-Invasive Glucose Monitoring Market Size by Type
        8.1.1 Asia Pacific Non-Invasive Glucose Monitoring Sales by Type (2017-2028)
        8.1.2 Asia Pacific Non-Invasive Glucose Monitoring Revenue by Type (2017-2028)
    8.2 Asia Pacific Non-Invasive Glucose Monitoring Market Size by Application
        8.2.1 Asia Pacific Non-Invasive Glucose Monitoring Sales by Application (2017-2028)
        8.2.2 Asia Pacific Non-Invasive Glucose Monitoring Revenue by Application (2017-2028)
    8.3 Asia Pacific Non-Invasive Glucose Monitoring Market Size by Region
        8.3.1 Asia Pacific Non-Invasive Glucose Monitoring Sales by Region (2017-2028)
        8.3.2 Asia Pacific Non-Invasive Glucose Monitoring Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 China Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
9 Latin America
    9.1 Latin America Non-Invasive Glucose Monitoring Market Size by Type
        9.1.1 Latin America Non-Invasive Glucose Monitoring Sales by Type (2017-2028)
        9.1.2 Latin America Non-Invasive Glucose Monitoring Revenue by Type (2017-2028)
    9.2 Latin America Non-Invasive Glucose Monitoring Market Size by Application
        9.2.1 Latin America Non-Invasive Glucose Monitoring Sales by Application (2017-2028)
        9.2.2 Latin America Non-Invasive Glucose Monitoring Revenue by Application (2017-2028)
    9.3 Latin America Non-Invasive Glucose Monitoring Market Size by Country
        9.3.1 Latin America Non-Invasive Glucose Monitoring Sales by Country (2017-2028)
        9.3.2 Latin America Non-Invasive Glucose Monitoring Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Non-Invasive Glucose Monitoring Market Size by Type
        10.1.1 Middle East and Africa Non-Invasive Glucose Monitoring Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Non-Invasive Glucose Monitoring Revenue by Type (2017-2028)
    10.2 Middle East and Africa Non-Invasive Glucose Monitoring Market Size by Application
        10.2.1 Middle East and Africa Non-Invasive Glucose Monitoring Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Non-Invasive Glucose Monitoring Revenue by Application (2017-2028)
    10.3 Middle East and Africa Non-Invasive Glucose Monitoring Market Size by Country
        10.3.1 Middle East and Africa Non-Invasive Glucose Monitoring Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Non-Invasive Glucose Monitoring Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Abbott
        11.1.1 Abbott Corporation Information
        11.1.2 Abbott Overview
        11.1.3 Abbott Non-Invasive Glucose Monitoring Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Abbott Non-Invasive Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Abbott Recent Developments
    11.2 Medtronic
        11.2.1 Medtronic Corporation Information
        11.2.2 Medtronic Overview
        11.2.3 Medtronic Non-Invasive Glucose Monitoring Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Medtronic Non-Invasive Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Medtronic Recent Developments
    11.3 Roche
        11.3.1 Roche Corporation Information
        11.3.2 Roche Overview
        11.3.3 Roche Non-Invasive Glucose Monitoring Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Roche Non-Invasive Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Roche Recent Developments
    11.4 Bayer AG
        11.4.1 Bayer AG Corporation Information
        11.4.2 Bayer AG Overview
        11.4.3 Bayer AG Non-Invasive Glucose Monitoring Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Bayer AG Non-Invasive Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Bayer AG Recent Developments
    11.5 B. Braun
        11.5.1 B. Braun Corporation Information
        11.5.2 B. Braun Overview
        11.5.3 B. Braun Non-Invasive Glucose Monitoring Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 B. Braun Non-Invasive Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 B. Braun Recent Developments
    11.6 Nipro Diagnostics
        11.6.1 Nipro Diagnostics Corporation Information
        11.6.2 Nipro Diagnostics Overview
        11.6.3 Nipro Diagnostics Non-Invasive Glucose Monitoring Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Nipro Diagnostics Non-Invasive Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Nipro Diagnostics Recent Developments
    11.7 Life Scan Inc.(J&J)
        11.7.1 Life Scan Inc.(J&J) Corporation Information
        11.7.2 Life Scan Inc.(J&J) Overview
        11.7.3 Life Scan Inc.(J&J) Non-Invasive Glucose Monitoring Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Life Scan Inc.(J&J) Non-Invasive Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Life Scan Inc.(J&J) Recent Developments
    11.8 Arkray Devices
        11.8.1 Arkray Devices Corporation Information
        11.8.2 Arkray Devices Overview
        11.8.3 Arkray Devices Non-Invasive Glucose Monitoring Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Arkray Devices Non-Invasive Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Arkray Devices Recent Developments
    11.9 Nova Biomedical
        11.9.1 Nova Biomedical Corporation Information
        11.9.2 Nova Biomedical Overview
        11.9.3 Nova Biomedical Non-Invasive Glucose Monitoring Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Nova Biomedical Non-Invasive Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Nova Biomedical Recent Developments
    11.10 Bionime Corporation
        11.10.1 Bionime Corporation Corporation Information
        11.10.2 Bionime Corporation Overview
        11.10.3 Bionime Corporation Non-Invasive Glucose Monitoring Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Bionime Corporation Non-Invasive Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Bionime Corporation Recent Developments
    11.11 Sinocare
        11.11.1 Sinocare Corporation Information
        11.11.2 Sinocare Overview
        11.11.3 Sinocare Non-Invasive Glucose Monitoring Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Sinocare Non-Invasive Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Sinocare Recent Developments
    11.12 Hybio Pharmaceutical
        11.12.1 Hybio Pharmaceutical Corporation Information
        11.12.2 Hybio Pharmaceutical Overview
        11.12.3 Hybio Pharmaceutical Non-Invasive Glucose Monitoring Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Hybio Pharmaceutical Non-Invasive Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Hybio Pharmaceutical Recent Developments
    11.13 Lepu Medical
        11.13.1 Lepu Medical Corporation Information
        11.13.2 Lepu Medical Overview
        11.13.3 Lepu Medical Non-Invasive Glucose Monitoring Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Lepu Medical Non-Invasive Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Lepu Medical Recent Developments
    11.14 Yuyue Medical
        11.14.1 Yuyue Medical Corporation Information
        11.14.2 Yuyue Medical Overview
        11.14.3 Yuyue Medical Non-Invasive Glucose Monitoring Sales, Price, Revenue and Gross Margin (2017-2022)
        11.14.4 Yuyue Medical Non-Invasive Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
        11.14.5 Yuyue Medical Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Non-Invasive Glucose Monitoring Industry Chain Analysis
    12.2 Non-Invasive Glucose Monitoring Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Non-Invasive Glucose Monitoring Production Mode & Process
    12.4 Non-Invasive Glucose Monitoring Sales and Marketing
        12.4.1 Non-Invasive Glucose Monitoring Sales Channels
        12.4.2 Non-Invasive Glucose Monitoring Distributors
    12.5 Non-Invasive Glucose Monitoring Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Non-Invasive Glucose Monitoring Industry Trends
    13.2 Non-Invasive Glucose Monitoring Market Drivers
    13.3 Non-Invasive Glucose Monitoring Market Challenges
    13.4 Non-Invasive Glucose Monitoring Market Restraints
14 Key Findings in The Global Non-Invasive Glucose Monitoring Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Non-Invasive Glucose Monitoring Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Wearable Blood Glucose Monitoring Systems
    Table 3. Major Manufacturers of Table Top Blood Glucose Monitoring Systems
    Table 4. Global Non-Invasive Glucose Monitoring Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Non-Invasive Glucose Monitoring Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Non-Invasive Glucose Monitoring Sales by Region (2017-2022) & (K Units)
    Table 7. Global Non-Invasive Glucose Monitoring Sales Market Share by Region (2017-2022)
    Table 8. Global Non-Invasive Glucose Monitoring Sales by Region (2023-2028) & (K Units)
    Table 9. Global Non-Invasive Glucose Monitoring Sales Market Share by Region (2023-2028)
    Table 10. Global Non-Invasive Glucose Monitoring Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Non-Invasive Glucose Monitoring Revenue Market Share by Region (2017-2022)
    Table 12. Global Non-Invasive Glucose Monitoring Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Non-Invasive Glucose Monitoring Revenue Market Share by Region (2023-2028)
    Table 14. Global Non-Invasive Glucose Monitoring Sales by Manufacturers (2017-2022) & (K Units)
    Table 15. Global Non-Invasive Glucose Monitoring Sales Share by Manufacturers (2017-2022)
    Table 16. Global Non-Invasive Glucose Monitoring Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Non-Invasive Glucose Monitoring Revenue Share by Manufacturers (2017-2022)
    Table 18. Non-Invasive Glucose Monitoring Price by Manufacturers (2017-2022) &(US$/Unit)
    Table 19. Global Non-Invasive Glucose Monitoring Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Non-Invasive Glucose Monitoring by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Glucose Monitoring as of 2021)
    Table 21. Non-Invasive Glucose Monitoring Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Non-Invasive Glucose Monitoring Product Offered
    Table 23. Date of Manufacturers Enter into Non-Invasive Glucose Monitoring Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Non-Invasive Glucose Monitoring Sales by Type (2017-2022) & (K Units)
    Table 26. Global Non-Invasive Glucose Monitoring Sales by Type (2023-2028) & (K Units)
    Table 27. Global Non-Invasive Glucose Monitoring Sales Share by Type (2017-2022)
    Table 28. Global Non-Invasive Glucose Monitoring Sales Share by Type (2023-2028)
    Table 29. Global Non-Invasive Glucose Monitoring Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Non-Invasive Glucose Monitoring Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Non-Invasive Glucose Monitoring Revenue Share by Type (2017-2022)
    Table 32. Global Non-Invasive Glucose Monitoring Revenue Share by Type (2023-2028)
    Table 33. Non-Invasive Glucose Monitoring Price by Type (2017-2022) & (US$/Unit)
    Table 34. Global Non-Invasive Glucose Monitoring Price Forecast by Type (2023-2028) & (US$/Unit)
    Table 35. Global Non-Invasive Glucose Monitoring Sales by Application (2017-2022) & (K Units)
    Table 36. Global Non-Invasive Glucose Monitoring Sales by Application (2023-2028) & (K Units)
    Table 37. Global Non-Invasive Glucose Monitoring Sales Share by Application (2017-2022)
    Table 38. Global Non-Invasive Glucose Monitoring Sales Share by Application (2023-2028)
    Table 39. Global Non-Invasive Glucose Monitoring Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Non-Invasive Glucose Monitoring Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Non-Invasive Glucose Monitoring Revenue Share by Application (2017-2022)
    Table 42. Global Non-Invasive Glucose Monitoring Revenue Share by Application (2023-2028)
    Table 43. Non-Invasive Glucose Monitoring Price by Application (2017-2022) & (US$/Unit)
    Table 44. Global Non-Invasive Glucose Monitoring Price Forecast by Application (2023-2028) & (US$/Unit)
    Table 45. North America Non-Invasive Glucose Monitoring Sales by Type (2017-2022) & (K Units)
    Table 46. North America Non-Invasive Glucose Monitoring Sales by Type (2023-2028) & (K Units)
    Table 47. North America Non-Invasive Glucose Monitoring Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Non-Invasive Glucose Monitoring Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Non-Invasive Glucose Monitoring Sales by Application (2017-2022) & (K Units)
    Table 50. North America Non-Invasive Glucose Monitoring Sales by Application (2023-2028) & (K Units)
    Table 51. North America Non-Invasive Glucose Monitoring Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Non-Invasive Glucose Monitoring Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Non-Invasive Glucose Monitoring Sales by Country (2017-2022) & (K Units)
    Table 54. North America Non-Invasive Glucose Monitoring Sales by Country (2023-2028) & (K Units)
    Table 55. North America Non-Invasive Glucose Monitoring Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Non-Invasive Glucose Monitoring Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Non-Invasive Glucose Monitoring Sales by Type (2017-2022) & (K Units)
    Table 58. Europe Non-Invasive Glucose Monitoring Sales by Type (2023-2028) & (K Units)
    Table 59. Europe Non-Invasive Glucose Monitoring Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Non-Invasive Glucose Monitoring Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Non-Invasive Glucose Monitoring Sales by Application (2017-2022) & (K Units)
    Table 62. Europe Non-Invasive Glucose Monitoring Sales by Application (2023-2028) & (K Units)
    Table 63. Europe Non-Invasive Glucose Monitoring Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Non-Invasive Glucose Monitoring Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Non-Invasive Glucose Monitoring Sales by Country (2017-2022) & (K Units)
    Table 66. Europe Non-Invasive Glucose Monitoring Sales by Country (2023-2028) & (K Units)
    Table 67. Europe Non-Invasive Glucose Monitoring Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Non-Invasive Glucose Monitoring Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Non-Invasive Glucose Monitoring Sales by Type (2017-2022) & (K Units)
    Table 70. Asia Pacific Non-Invasive Glucose Monitoring Sales by Type (2023-2028) & (K Units)
    Table 71. Asia Pacific Non-Invasive Glucose Monitoring Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Non-Invasive Glucose Monitoring Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Non-Invasive Glucose Monitoring Sales by Application (2017-2022) & (K Units)
    Table 74. Asia Pacific Non-Invasive Glucose Monitoring Sales by Application (2023-2028) & (K Units)
    Table 75. Asia Pacific Non-Invasive Glucose Monitoring Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Non-Invasive Glucose Monitoring Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Non-Invasive Glucose Monitoring Sales by Region (2017-2022) & (K Units)
    Table 78. Asia Pacific Non-Invasive Glucose Monitoring Sales by Region (2023-2028) & (K Units)
    Table 79. Asia Pacific Non-Invasive Glucose Monitoring Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Non-Invasive Glucose Monitoring Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Non-Invasive Glucose Monitoring Sales by Type (2017-2022) & (K Units)
    Table 82. Latin America Non-Invasive Glucose Monitoring Sales by Type (2023-2028) & (K Units)
    Table 83. Latin America Non-Invasive Glucose Monitoring Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Non-Invasive Glucose Monitoring Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Non-Invasive Glucose Monitoring Sales by Application (2017-2022) & (K Units)
    Table 86. Latin America Non-Invasive Glucose Monitoring Sales by Application (2023-2028) & (K Units)
    Table 87. Latin America Non-Invasive Glucose Monitoring Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Non-Invasive Glucose Monitoring Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Non-Invasive Glucose Monitoring Sales by Country (2017-2022) & (K Units)
    Table 90. Latin America Non-Invasive Glucose Monitoring Sales by Country (2023-2028) & (K Units)
    Table 91. Latin America Non-Invasive Glucose Monitoring Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Non-Invasive Glucose Monitoring Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Non-Invasive Glucose Monitoring Sales by Type (2017-2022) & (K Units)
    Table 94. Middle East and Africa Non-Invasive Glucose Monitoring Sales by Type (2023-2028) & (K Units)
    Table 95. Middle East and Africa Non-Invasive Glucose Monitoring Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Non-Invasive Glucose Monitoring Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Non-Invasive Glucose Monitoring Sales by Application (2017-2022) & (K Units)
    Table 98. Middle East and Africa Non-Invasive Glucose Monitoring Sales by Application (2023-2028) & (K Units)
    Table 99. Middle East and Africa Non-Invasive Glucose Monitoring Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Non-Invasive Glucose Monitoring Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Non-Invasive Glucose Monitoring Sales by Country (2017-2022) & (K Units)
    Table 102. Middle East and Africa Non-Invasive Glucose Monitoring Sales by Country (2023-2028) & (K Units)
    Table 103. Middle East and Africa Non-Invasive Glucose Monitoring Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Non-Invasive Glucose Monitoring Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Abbott Corporation Information
    Table 106. Abbott Description and Major Businesses
    Table 107. Abbott Non-Invasive Glucose Monitoring Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 108. Abbott Non-Invasive Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Abbott Recent Developments
    Table 110. Medtronic Corporation Information
    Table 111. Medtronic Description and Major Businesses
    Table 112. Medtronic Non-Invasive Glucose Monitoring Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 113. Medtronic Non-Invasive Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Medtronic Recent Developments
    Table 115. Roche Corporation Information
    Table 116. Roche Description and Major Businesses
    Table 117. Roche Non-Invasive Glucose Monitoring Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 118. Roche Non-Invasive Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Roche Recent Developments
    Table 120. Bayer AG Corporation Information
    Table 121. Bayer AG Description and Major Businesses
    Table 122. Bayer AG Non-Invasive Glucose Monitoring Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 123. Bayer AG Non-Invasive Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Bayer AG Recent Developments
    Table 125. B. Braun Corporation Information
    Table 126. B. Braun Description and Major Businesses
    Table 127. B. Braun Non-Invasive Glucose Monitoring Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 128. B. Braun Non-Invasive Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. B. Braun Recent Developments
    Table 130. Nipro Diagnostics Corporation Information
    Table 131. Nipro Diagnostics Description and Major Businesses
    Table 132. Nipro Diagnostics Non-Invasive Glucose Monitoring Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 133. Nipro Diagnostics Non-Invasive Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Nipro Diagnostics Recent Developments
    Table 135. Life Scan Inc.(J&J) Corporation Information
    Table 136. Life Scan Inc.(J&J) Description and Major Businesses
    Table 137. Life Scan Inc.(J&J) Non-Invasive Glucose Monitoring Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 138. Life Scan Inc.(J&J) Non-Invasive Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Life Scan Inc.(J&J) Recent Developments
    Table 140. Arkray Devices Corporation Information
    Table 141. Arkray Devices Description and Major Businesses
    Table 142. Arkray Devices Non-Invasive Glucose Monitoring Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 143. Arkray Devices Non-Invasive Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Arkray Devices Recent Developments
    Table 145. Nova Biomedical Corporation Information
    Table 146. Nova Biomedical Description and Major Businesses
    Table 147. Nova Biomedical Non-Invasive Glucose Monitoring Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 148. Nova Biomedical Non-Invasive Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Nova Biomedical Recent Developments
    Table 150. Bionime Corporation Corporation Information
    Table 151. Bionime Corporation Description and Major Businesses
    Table 152. Bionime Corporation Non-Invasive Glucose Monitoring Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 153. Bionime Corporation Non-Invasive Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Bionime Corporation Recent Developments
    Table 155. Sinocare Corporation Information
    Table 156. Sinocare Description and Major Businesses
    Table 157. Sinocare Non-Invasive Glucose Monitoring Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 158. Sinocare Non-Invasive Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
    Table 159. Sinocare Recent Developments
    Table 160. Hybio Pharmaceutical Corporation Information
    Table 161. Hybio Pharmaceutical Description and Major Businesses
    Table 162. Hybio Pharmaceutical Non-Invasive Glucose Monitoring Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 163. Hybio Pharmaceutical Non-Invasive Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
    Table 164. Hybio Pharmaceutical Recent Developments
    Table 165. Lepu Medical Corporation Information
    Table 166. Lepu Medical Description and Major Businesses
    Table 167. Lepu Medical Non-Invasive Glucose Monitoring Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 168. Lepu Medical Non-Invasive Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
    Table 169. Lepu Medical Recent Developments
    Table 170. Yuyue Medical Corporation Information
    Table 171. Yuyue Medical Description and Major Businesses
    Table 172. Yuyue Medical Non-Invasive Glucose Monitoring Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 173. Yuyue Medical Non-Invasive Glucose Monitoring Product Model Numbers, Pictures, Descriptions and Specifications
    Table 174. Yuyue Medical Recent Developments
    Table 175. Key Raw Materials Lists
    Table 176. Raw Materials Key Suppliers Lists
    Table 177. Non-Invasive Glucose Monitoring Distributors List
    Table 178. Non-Invasive Glucose Monitoring Customers List
    Table 179. Non-Invasive Glucose Monitoring Market Trends
    Table 180. Non-Invasive Glucose Monitoring Market Drivers
    Table 181. Non-Invasive Glucose Monitoring Market Challenges
    Table 182. Non-Invasive Glucose Monitoring Market Restraints
    Table 183. Research Programs/Design for This Report
    Table 184. Key Data Information from Secondary Sources
    Table 185. Key Data Information from Primary Sources
List of Figures
    Figure 1. Non-Invasive Glucose Monitoring Product Picture
    Figure 3. Global Non-Invasive Glucose Monitoring Market Share by Type in 2021 & 2028
    Figure 3. Wearable Blood Glucose Monitoring Systems Product Picture
    Figure 4. Table Top Blood Glucose Monitoring Systems Product Picture
    Figure 5. Global Non-Invasive Glucose Monitoring Market Share by Application in 2021 & 2028
    Figure 6. Hospitals
    Figure 7. Clinics
    Figure 8. Others
    Figure 9. Non-Invasive Glucose Monitoring Report Years Considered
    Figure 10. Global Non-Invasive Glucose Monitoring Sales 2017-2028 (K Units)
    Figure 11. Global Non-Invasive Glucose Monitoring Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Non-Invasive Glucose Monitoring Revenue 2017-2028 (US$ Million)
    Figure 13. Global Non-Invasive Glucose Monitoring Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Non-Invasive Glucose Monitoring Sales Market Share by Region (2017-2022)
    Figure 15. Global Non-Invasive Glucose Monitoring Sales Market Share by Region (2023-2028)
    Figure 16. North America Non-Invasive Glucose Monitoring Sales YoY (2017-2028) & (K Units)
    Figure 17. North America Non-Invasive Glucose Monitoring Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Non-Invasive Glucose Monitoring Sales YoY (2017-2028) & (K Units)
    Figure 19. Europe Non-Invasive Glucose Monitoring Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Non-Invasive Glucose Monitoring Sales YoY (2017-2028) & (K Units)
    Figure 21. Asia-Pacific Non-Invasive Glucose Monitoring Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Non-Invasive Glucose Monitoring Sales YoY (2017-2028) & (K Units)
    Figure 23. Latin America Non-Invasive Glucose Monitoring Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Non-Invasive Glucose Monitoring Sales YoY (2017-2028) & (K Units)
    Figure 25. Middle East & Africa Non-Invasive Glucose Monitoring Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Non-Invasive Glucose Monitoring Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Non-Invasive Glucose Monitoring in the World: Market Share by Non-Invasive Glucose Monitoring Revenue in 2021
    Figure 28. Global Non-Invasive Glucose Monitoring Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Non-Invasive Glucose Monitoring Sales Market Share by Type (2017-2028)
    Figure 30. Global Non-Invasive Glucose Monitoring Revenue Market Share by Type (2017-2028)
    Figure 31. Global Non-Invasive Glucose Monitoring Sales Market Share by Application (2017-2028)
    Figure 32. Global Non-Invasive Glucose Monitoring Revenue Market Share by Application (2017-2028)
    Figure 33. North America Non-Invasive Glucose Monitoring Sales Market Share by Type (2017-2028)
    Figure 34. North America Non-Invasive Glucose Monitoring Revenue Market Share by Type (2017-2028)
    Figure 35. North America Non-Invasive Glucose Monitoring Sales Market Share by Application (2017-2028)
    Figure 36. North America Non-Invasive Glucose Monitoring Revenue Market Share by Application (2017-2028)
    Figure 37. North America Non-Invasive Glucose Monitoring Sales Share by Country (2017-2028)
    Figure 38. North America Non-Invasive Glucose Monitoring Revenue Share by Country (2017-2028)
    Figure 39. United States Non-Invasive Glucose Monitoring Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Non-Invasive Glucose Monitoring Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Non-Invasive Glucose Monitoring Sales Market Share by Type (2017-2028)
    Figure 42. Europe Non-Invasive Glucose Monitoring Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Non-Invasive Glucose Monitoring Sales Market Share by Application (2017-2028)
    Figure 44. Europe Non-Invasive Glucose Monitoring Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Non-Invasive Glucose Monitoring Sales Share by Country (2017-2028)
    Figure 46. Europe Non-Invasive Glucose Monitoring Revenue Share by Country (2017-2028)
    Figure 47. Germany Non-Invasive Glucose Monitoring Revenue (2017-2028) & (US$ Million)
    Figure 48. France Non-Invasive Glucose Monitoring Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. Non-Invasive Glucose Monitoring Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Non-Invasive Glucose Monitoring Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Non-Invasive Glucose Monitoring Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Non-Invasive Glucose Monitoring Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Non-Invasive Glucose Monitoring Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Non-Invasive Glucose Monitoring Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Non-Invasive Glucose Monitoring Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Non-Invasive Glucose Monitoring Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Non-Invasive Glucose Monitoring Revenue Share by Region (2017-2028)
    Figure 58. China Non-Invasive Glucose Monitoring Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Non-Invasive Glucose Monitoring Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Non-Invasive Glucose Monitoring Revenue (2017-2028) & (US$ Million)
    Figure 61. India Non-Invasive Glucose Monitoring Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Non-Invasive Glucose Monitoring Revenue (2017-2028) & (US$ Million)
    Figure 63. China Taiwan Non-Invasive Glucose Monitoring Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Non-Invasive Glucose Monitoring Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Non-Invasive Glucose Monitoring Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Non-Invasive Glucose Monitoring Revenue (2017-2028) & (US$ Million)
    Figure 67. Latin America Non-Invasive Glucose Monitoring Sales Market Share by Type (2017-2028)
    Figure 68. Latin America Non-Invasive Glucose Monitoring Revenue Market Share by Type (2017-2028)
    Figure 69. Latin America Non-Invasive Glucose Monitoring Sales Market Share by Application (2017-2028)
    Figure 70. Latin America Non-Invasive Glucose Monitoring Revenue Market Share by Application (2017-2028)
    Figure 71. Latin America Non-Invasive Glucose Monitoring Sales Share by Country (2017-2028)
    Figure 72. Latin America Non-Invasive Glucose Monitoring Revenue Share by Country (2017-2028)
    Figure 73. Mexico Non-Invasive Glucose Monitoring Revenue (2017-2028) & (US$ Million)
    Figure 74. Brazil Non-Invasive Glucose Monitoring Revenue (2017-2028) & (US$ Million)
    Figure 75. Argentina Non-Invasive Glucose Monitoring Revenue (2017-2028) & (US$ Million)
    Figure 76. Middle East and Africa Non-Invasive Glucose Monitoring Sales Market Share by Type (2017-2028)
    Figure 77. Middle East and Africa Non-Invasive Glucose Monitoring Revenue Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Non-Invasive Glucose Monitoring Sales Market Share by Application (2017-2028)
    Figure 79. Middle East and Africa Non-Invasive Glucose Monitoring Revenue Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Non-Invasive Glucose Monitoring Sales Share by Country (2017-2028)
    Figure 81. Middle East and Africa Non-Invasive Glucose Monitoring Revenue Share by Country (2017-2028)
    Figure 82. Turkey Non-Invasive Glucose Monitoring Revenue (2017-2028) & (US$ Million)
    Figure 83. Saudi Arabia Non-Invasive Glucose Monitoring Revenue (2017-2028) & (US$ Million)
    Figure 84. UAE Non-Invasive Glucose Monitoring Revenue (2017-2028) & (US$ Million)
    Figure 85. Non-Invasive Glucose Monitoring Value Chain
    Figure 86. Non-Invasive Glucose Monitoring Production Process
    Figure 87. Channels of Distribution
    Figure 88. Distributors Profiles
    Figure 89. Bottom-up and Top-down Approaches for This Report
    Figure 90. Data Triangulation
    Figure 91. Key Executives Interviewed